<DrugInformationSummary id="CDR0000658573"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>The HPV bivalent vaccine protects against infection with high-risk HPV types 16 and 18, which cause most precancers and cancers of the cervix.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-HPV-bivalent-vaccine">Recombinant Human Papillomavirus (HPV) Bivalent Vaccine</DrugInfoURL><FDAApproved>No longer available in the U.S.</FDAApproved><TerminologyLink ref="CDR0000442270">recombinant human papillomavirus bivalent vaccine</TerminologyLink><GlossaryLink ref="CDR0000703577">recombinant human papillomavirus bivalent vaccine</GlossaryLink><USBrandNames><USBrandName>Cervarix</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>ree-KOM-bih-nunt HYOO-mun PA-pih-LOH-muh-VY-rus by-VAY-lent vak-SEEN</TermPronunciation><MediaLink ref="CDR0000732879" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000732880" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo></DrugInfoMetaData><DrugInfoTitle>Recombinant Human Papillomavirus (HPV) Bivalent Vaccine</DrugInfoTitle><Section><Para> </Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_5">   The HPV bivalent vaccine is used in females aged 10 to 25 years to prevent:</Para><ItemizedList Style="bullet" id="_3"><ListItem><Strong><GlossaryTermRef href="CDR0000444973" dictionary="Cancer.gov" audience="Patient">Cervical cancer</GlossaryTermRef>.</Strong></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046324" dictionary="Cancer.gov" audience="Patient">Lesions</GlossaryTermRef></Strong> that sometimes lead to cervical cancer.</ListItem></ItemizedList><Para id="_4">The recombinant HPV bivalent vaccine is no longer available in the United States. It is still used in other countries.</Para></Section><Section id="_About"><Title>More About Recombinant Human Papillomavirus (HPV) Bivalent Vaccine</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/442270">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.81">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a610014.html">Human Papillomavirus (HPV) Vaccine</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.82"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.83">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/cervical-cancer-hpv-vaccine-one-dose-kenya">More Evidence that One HPV Vaccine Dose Protects against Cancer-Causing Infections</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer">HPV and Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2021/hpv-vaccine-parents-safety-concerns">Despite Proven Safety of HPV Vaccines, More Parents Have Concerns</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet">Human Papillomavirus (HPV) Vaccines</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2020/hpv-vaccine-single-dose-long-term-protection">Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2019/men-oral-hpv-infection-vaccine-herd-immunity">HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2018/hpv-vaccine-presidents-cancer-panel-improving-uptake">The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C48395">Find Clinical Trials for Recombinant Human Papillomavirus Bivalent Vaccine</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2010-05-07</DateFirstPublished><DateLastModified>2023-03-10</DateLastModified></DrugInformationSummary>
